5-羟基癸酸钠盐  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:25mg 100mg in glass bottle
溶解性:溶于水(10mg/ml)
产品描述:基本信息 产品编号: H10488 产品名称: 5-Hydroxydecanoate sodium CAS: 71186-53-3   储存条件 粉末 2-8℃ 四年     分子式: C10H19NaO3 溶于液体 -80℃ 6个月 分子量: 210.25 -20℃ 1个月 化学名:  5-Hydroxydecanoic acid sodium salt,>=97% (HPLC) Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 4.7562mL 23.7812mL 47.5624mL 5mM 0.9512mL 4.7562mL 9.5125mL 10mM 0.4756mL 2.3781mL 4.7562mL 生物活性 产品描述 一种选择性ATP敏感的K+(KATP)通道阻滞剂(IC50约为30μM)。5-Hydroxydecanoatesodium是线粒体外膜酰基辅酶A合成酶的底物,并具有抗氧化活性。 靶点 IC50:~30μM (KATP)   体外研究 5-Hydroxydecanoate (5-HD) treatment abolishs the beneficial effects of penehyclidine hydrochloride (PHC) preconditioning in anoxia/reoxygenation (A/R)‐induced injury in H9c2 cells.5-Hydroxydecanoate blocks the inhibitory effect of PHC on Ca2+ overload and ROS production.5-Hydroxydecanoate promotes the release of Cyt-C from mitochondria into cytoplasm.5-Hydroxydecanoate attenuats the anti-apoptotic effect of PHC.PHC treatment shows remarkably decreases levels of Bax and cleaved caspase-3,and increases levels of Bcl-2.5-Hydroxydecanoate pretreatment reverses the effects of PHC on their expression levels.5-Hydroxydecanoate blocks the effects of PHC on KATP channels. 体内研究 5-Hydroxydecanoate (100μM) treatment abolishes the effects of ischemic preconditioning (IPC) on the contractile recovery and does not affect its effect on the contracture,lactate production,glycogenolysis and viable tissue in rats.
保存条件:2-8℃